SignalFDA/Bio

BridgeBio reports improved symptoms in Phase 3 trial of rare-disease drug

Phase 3 trial shows improved symptoms for rare-disease drug.

What changed

Phase 3 trial shows improved symptoms for rare-disease drug.

Why it matters

Phase 3 trial shows improved symptoms for rare-disease drug. — impact context not separately stored; see What changed.

Sources